Category: Providers

340B Health, Researchers Spar over Biosimilar Study

September 28, 2023 Rich Daly, Editor in Chief Views

Maureen Testoni, president and CEO of 340B Health, said she anticipates bipartisan legislation on drugmaker 340B contract pharmacy restrictions.

Researchers rejected criticism of a recent study in an academic journal they co-authored from the leader of a 340B hospital [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Drug Purchases Reached $53.7 Billion in 2022, HRSA Data Show

September 26, 2023 Tom Mirga, Editor at Large Views

Drug purchases under the 340B program totaled $53.7 billion in 2022, according to HRSA data obtained by Drug Channels.

Drug purchases under the 340B program totaled $53.7 billion in 2022, or 22.3% more than the $43.9 billion in 2021, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospital 340B Sites increased by 400% Over 11 Years, Analysis Finds

September 26, 2023 Rich Daly, Editor in Chief Views

A consulting firm analysis found that hospital 340B covered entity and child sites increased more than fourfold over the last 11 years.

Hospital 340B covered entity and child sites increased by more than 400% over the last 11 years, while the number [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Providers Try a Range of Responses to Manufacturer 340B Contract Pharmacy Restrictions

September 26, 2023 Rich Daly, Editor in Chief Views

Community health centers are attempting to mitigate the adverse financial effects of manufacturer 340B contract pharmacy restrictions on their organizations, said Colleen Meiman, national policy advisor for State & Regional Associations of Community Health Centers.

Amid an increasing number of drugmaker restrictions and requirements on the use of contract pharmacies, 340B providers are trying a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Expanding 340B Eligibility Could Double Program Size, Says Report

September 26, 2023 William Newton, Associate Editor/Senior Writer Views

An IQVIA analysis looked at the 340B program’s growth under the Affordable Care Act.

The 340B program could more than double in size if the 340B patient definition expands, according to a recent report [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Senate Committee Rejects 340B Amendment to Bipartisan Health Bill

September 26, 2023 William Newton, Associate Editor/Senior Writer Views

Sen. Bernie Sanders, chair of the Senate HELP committee, opposed an amendment that would implement 340B hospital verification requirements.

A Senate committee rejected an effort to add new 340B hospital verification requirements as part of a sweeping healthcare funding [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal Appeals Court Judges Press Both Sides in Key Hearing on Arkansas 340B Contract Pharmacy Law

September 21, 2023 William Newton, Associate Editor/Senior Writer Views

Chief Judge Lavenski Smith of the 8th Circuit Court of Appeals and two other federal judges heard highly anticipated oral arguments for PhRMA v. McClain in a case that challenges Arkansas' 340B contract pharmacy law.

Attorneys representing Arkansas and 340B providers sparred with a drug industry lawyer over the constitutionality of Arkansas’ first-in-the-nation 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Incyte Becomes 26th Drugmaker to Place Contract Pharmacy Restrictions

September 21, 2023 Rich Daly, Editor in Chief Views

Incyte will no longer allow 340B hospitals to have direct delivery of Opzelura products purchased at the 340B discount price to contract pharmacies.

Drug manufacturer Incyte Corp. this week announced it will become the 26th drug manufacturer to restrict access to 340B pricing when [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

One Quarter of HRSA Provider Audits Closed with No Adverse Findings

September 21, 2023 Rich Daly, Editor in Chief Views

Dept. of Health and Human Services sign and building

There were no adverse findings in nearly one quarter of provider audits conducted by HRSA, an agency within HHS.

Nearly one-quarter of the 200 provider audits planned for this year were closed by regulators with no adverse findings, they [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Providers Split on 340B Medicaid Provisions in Major House Healthcare Package

September 19, 2023 William Newton, Associate Editor/Senior Writer Views

Joe Dunn, senior vice president of public policy and research at NACHC, said his organization supported the Lower Costs, More Transparency Act.

Provider groups diverged over 340B Medicaid managed care provisions in a sweeping healthcare package on which the House of Representatives [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live